VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Free Report) announced a quarterly dividend on Monday, March 31st, NASDAQ Dividends reports. Stockholders of record on Tuesday, April 1st will be given a dividend of 0.5245 per share on Friday, April 4th. This represents a $2.10 dividend on an annualized basis and a dividend yield of 2.36%. The ex-dividend date is Tuesday, April 1st. This is a 70.6% increase from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.
VanEck Pharmaceutical ETF Stock Performance
NASDAQ PPH traded down $2.40 during trading hours on Tuesday, reaching $88.73. 96,738 shares of the company’s stock were exchanged, compared to its average volume of 188,975. The company has a market capitalization of $553.68 million, a price-to-earnings ratio of 27.82 and a beta of 0.72. The company’s 50-day moving average is $90.90 and its two-hundred day moving average is $90.60. VanEck Pharmaceutical ETF has a one year low of $84.48 and a one year high of $99.51.
About VanEck Pharmaceutical ETF
Recommended Stories
- Five stocks we like better than VanEck Pharmaceutical ETF
- ESG Stocks, What Investors Should Know
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Stock Average Calculator
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.
